id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT02473536
15:33:cancer
Any number of metastatic disease is allowed in the Pilot phase of the trial
2
[ "Any", "number", "of", "metastatic", "disease", "is", "allowed", "in", "the", "Pilot", "phase", "of", "the", "trial" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02995590
12:14:chronic_disease,16:22:chronic_disease,48:60:chronic_disease
History of MI, stroke and/or poorly controlled hypertension
2
[ "History", "of", "MI", ",", "stroke", "and/or", "poorly", "controlled", "hypertension" ]
[ 0, 0, 2, 0, 2, 0, 0, 0, 2 ]
NCT02547818
41:67:treatment
Visual and auditory acuity adequate for neuropsychological testing
2
[ "Visual", "and", "auditory", "acuity", "adequate", "for", "neuropsychological", "testing" ]
[ 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02587936
1:16:chronic_disease
Type 2 diabetes included in problem list
2
[ "Type", "2", "diabetes", "included", "in", "problem", "list" ]
[ 2, 2, 2, 0, 0, 0, 0 ]
NCT02521818
52:72:chronic_disease
availability of cohabitating study partner without cognitive impairment
2
[ "availability", "of", "cohabitating", "study", "partner", "without", "cognitive", "impairment" ]
[ 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT02418195
1:33:chronic_disease
Pervasive developmental disorder
2
[ "Pervasive", "developmental", "disorder" ]
[ 2, 2, 2 ]
NCT02172950
,,,,62:85:chronic_disease,,,,
Males 0 to <65 years age who have been diagnosed with severe congenital hemophilia A (FVIII activity levels < 1%), who have at least 50 EDs to any FVIII product, and who are not currently enrolled in a CSL-sponsored clinical study with rVIII-SingleChain
2
[ "Males", "0", "to", "<", "65", "years", "age", "who", "have", "been", "diagnosed", "with", "severe", "congenital", "hemophilia", "A", "(", "FVIII", "activity", "levels", "<", "1", "%", ")", ",", "who", "have", "at", "least", "50", "EDs", "to", "any", ...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01994538
1:10:treatment,29:58:treatment
Treatment initiated with an empiric antimicrobial regimen that is underdosed, based on current guidelines and reviews
2
[ "Treatment", "initiated", "with", "an", "empiric", "antimicrobial", "regimen", "that", "is", "underdosed", ",", "based", "on", "current", "guidelines", "and", "reviews" ]
[ 1, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02607748
1:17:chronic_disease,56:88:treatment,,148:151:chronic_disease,,
Asymptomatic CAD group: 40 patients who have undergone Coronary Artery Calcium scanning within 6 months prior to the imaging visit, matched to the ACS patients for age, gender, and CAC score
2
[ "Asymptomatic", "CAD", "group", ":", "40", "patients", "who", "have", "undergone", "Coronary", "Artery", "Calcium", "scanning", "within", "6", "months", "prior", "to", "the", "imaging", "visit", ",", "matched", "to", "the", "ACS", "patients", "for", "age", "...
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02578732
15:33:cancer
Patients with metastatic disease
2
[ "Patients", "with", "metastatic", "disease" ]
[ 0, 0, 3, 3 ]
NCT02548351
1:16:chronic_disease
Type 2 diabetes diagnosed per 2013 American Diabetes Association criteria
2
[ "Type", "2", "diabetes", "diagnosed", "per", "2013", "American", "Diabetes", "Association", "criteria" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02519322
26:37:chronic_disease
Subjects with history of myocarditis, regardless of etiology
2
[ "Subjects", "with", "history", "of", "myocarditis", ",", "regardless", "of", "etiology" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 0 ]
NCT02213289
12:30:cancer
Measurable metastatic disease
2
[ "Measurable", "metastatic", "disease" ]
[ 0, 3, 3 ]
NCT02664168
48:86:treatment
Skin integrity issues that preclude the use of Negative Pressure Wound Therapy (NPWT)
2
[ "Skin", "integrity", "issues", "that", "preclude", "the", "use", "of", "Negative", "Pressure", "Wound", "Therapy", "(", "NPWT", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0 ]
NCT02159703
13:15:chronic_disease,19:29:chronic_disease,33:48:treatment
Presence of N0 or N1 disease in neck dissection
2
[ "Presence", "of", "N0", "or", "N1", "disease", "in", "neck", "dissection" ]
[ 0, 0, 2, 0, 2, 2, 0, 1, 1 ]
NCT02489045
15:44:chronic_disease
Patients with respiratory distress syndrome
2
[ "Patients", "with", "respiratory", "distress", "syndrome" ]
[ 0, 0, 2, 2, 2 ]
NCT02669030
14:28:treatment
Currently on antidepressant
2
[ "Currently", "on", "antidepressant" ]
[ 0, 0, 1 ]
NCT02521818
1:14:allergy_name
multiple food allergies
2
[ "multiple", "food", "allergies" ]
[ 4, 4, 0 ]
NCT02353728
12:27:chronic_disease,
History of unstable angina within 1 year of study entry
2
[ "History", "of", "unstable", "angina", "within", "1", "year", "of", "study", "entry" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02570854
12:23:chronic_disease
A positive Hepatitis B surface antigen test result
2
[ "A", "positive", "Hepatitis", "B", "surface", "antigen", "test", "result" ]
[ 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT02589977
34:36:chronic_disease
physician-confirmed diagnosis of HF
2
[ "physician-confirmed", "diagnosis", "of", "HF" ]
[ 0, 0, 0, 2 ]
NCT00285935
11:30:treatment,88:95:treatment,99:110:treatment,138:157:treatment,161:169:treatment
Taking no medication or drugs likely to interfere with the study objectives (including statins or medications that affect hormones [e.g. birth control pills or steroids])
2
[ "Taking", "no", "medication", "or", "drugs", "likely", "to", "interfere", "with", "the", "study", "objectives", "(", "including", "statins", "or", "medications", "that", "affect", "hormones", "[", "e.g", ".", "birth", "control", "pills", "or", "steroids", "]",...
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 0 ]
NCT03112590
31:54:treatment,75:86:treatment,91:101:treatment
Must be candidates to receive paclitaxel chemotherapy in combination with trastuzumab and pertuzumab
2
[ "Must", "be", "candidates", "to", "receive", "paclitaxel", "chemotherapy", "in", "combination", "with", "trastuzumab", "and", "pertuzumab" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 1, 0, 1 ]
NCT03036098
44:57:treatment
Patients with disease that is suitable for local therapy administered
2
[ "Patients", "with", "disease", "that", "is", "suitable", "for", "local", "therapy", "administered" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT02323880
1:16:treatment,69:82:treatment,,132:146:treatment
Corticosteroids: If used to modify immune adverse events related to prior therapy, >= 14 days must have elapsed since last dose of corticosteroid
2
[ "Corticosteroids", ":", "If", "used", "to", "modify", "immune", "adverse", "events", "related", "to", "prior", "therapy", ",", ">", "=", "14", "days", "must", "have", "elapsed", "since", "last", "dose", "of", "corticosteroid" ]
[ 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03058029
12:18:cancer,
History of cancer within the past five(5) years
2
[ "History", "of", "cancer", "within", "the", "past", "five", "(", "5", ")", "years" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02498613
1:36:treatment
Prior treatment with anthracyclines
2
[ "Prior", "treatment", "with", "anthracyclines" ]
[ 1, 1, 1, 1 ]
NCT02349867
14:23:treatment,36:46:cancer,,99:117:treatment,121:141:cancer,145:180:cancer,189:204:cancer,218:233:cancer,240:256:treatment
Diagnosis or treatment for another malignancy within 3 years of enrollment, with the exception of complete resection of basal cell carcinoma or squamous cell carcinoma of the skin, any in situ malignancy, or low-risk prostate cancer after curative therapy
2
[ "Diagnosis", "or", "treatment", "for", "another", "malignancy", "within", "3", "years", "of", "enrollment", ",", "with", "the", "exception", "of", "complete", "resection", "of", "basal", "cell", "carcinoma", "or", "squamous", "cell", "carcinoma", "of", "the", ...
[ 0, 0, 1, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 3, 3, 3, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0, 3, 3, 0, 0, 0, 3, 3, 0, 1, 1 ]
NCT02312245
21:42:treatment,74:83:treatment,92:108:cancer
Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm
2
[ "Receiving", "any", "other", "investigational", "agent", "which", "would", "be", "considered", "as", "a", "treatment", "for", "the", "primary", "neoplasm" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 0, 0, 3, 3 ]
NCT02159703
14:34:chronic_disease
Uncontrolled intercurrent illness
2
[ "Uncontrolled", "intercurrent", "illness" ]
[ 0, 2, 2 ]
NCT01415882
1:14:treatment,24:44:treatment,56:66:treatment,70:81:treatment
Prior therapy with any proteasome inhibitor other than bortezomib or carfilzomib
2
[ "Prior", "therapy", "with", "any", "proteasome", "inhibitor", "other", "than", "bortezomib", "or", "carfilzomib" ]
[ 1, 1, 0, 0, 1, 1, 0, 0, 1, 0, 1 ]
NCT01538966
31:41:chronic_disease,59:66:treatment,70:85:treatment
Newly diagnosed patients with acromegaly who have not had surgery or medical therapy
2
[ "Newly", "diagnosed", "patients", "with", "acromegaly", "who", "have", "not", "had", "surgery", "or", "medical", "therapy" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 1, 0, 1, 1 ]
NCT00291525
1:28:treatment
Concomitant cardiac surgery
2
[ "Concomitant", "cardiac", "surgery" ]
[ 1, 1, 1 ]
NCT02544880
8:23:treatment,32:53:treatment,55:74:treatment,80:108:treatment,
Use of PDE5 inhibitors such as vardenafil (Levitra®), Tadalafil (Cialis®), and sildenafil citrate (Viagra®) ≤15-days prior to (intended) enrollment
2
[ "Use", "of", "PDE5", "inhibitors", "such", "as", "vardenafil", "(", "Levitra®", ")", ",", "Tadalafil", "(", "Cialis®", ")", ",", "and", "sildenafil", "citrate", "(", "Viagra®", ")", "≤15-days", "prior", "to", "(", "intended", ")", "enrollment" ]
[ 0, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 1, 1, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02462590
29:47:chronic_disease
primary diagnosis of severe acute pancreatitis, without reference to a Ranson score [Ranson 1974])
2
[ "primary", "diagnosis", "of", "severe", "acute", "pancreatitis", ",", "without", "reference", "to", "a", "Ranson", "score", "[", "Ranson", "1974", "]", ")" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03119363
24:41:chronic_disease,80:86:chronic_disease,105:115:treatment,,
Confounding underlying medical illnesses which may cause fatigue (e.g., severe Anemia not controlled by medication, per self-report corroborated by medical chart review (e.g., Hb<10gm/dl)
2
[ "Confounding", "underlying", "medical", "illnesses", "which", "may", "cause", "fatigue", "(", "e.g.", ",", "severe", "Anemia", "not", "controlled", "by", "medication", ",", "per", "self-report", "corroborated", "by", "medical", "chart", "review", "(", "e.g.", ",...
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02857218
27:40:chronic_disease
Subjects with evidence of iron overload
2
[ "Subjects", "with", "evidence", "of", "iron", "overload" ]
[ 0, 0, 0, 0, 2, 2 ]
NCT02148003
41:56:chronic_disease
Subjects who have an active systemic or local infection
2
[ "Subjects", "who", "have", "an", "active", "systemic", "or", "local", "infection" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 2 ]
NCT03136029
30:38:chronic_disease
These include a diagnosis of Dementia
2
[ "These", "include", "a", "diagnosis", "of", "Dementia" ]
[ 0, 0, 0, 0, 0, 2 ]
NCT02255383
1:21:chronic_disease,23:37:chronic_disease,39:58:chronic_disease,60:73:chronic_disease
rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis
2
[ "rheumatoid", "arthritis", ",", "osteoarthritis", ",", "traumatic", "arthritis", ",", "polyarthritis" ]
[ 2, 2, 0, 2, 0, 2, 2, 0, 2 ]
NCT03175978
21:30:chronic_disease
Active uncontrolled infection or severe systemic infection (enrollment is possible after control of infection)
2
[ "Active", "uncontrolled", "infection", "or", "severe", "systemic", "infection", "(", "enrollment", "is", "possible", "after", "control", "of", "infection", ")" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01943851
34:37:treatment
Otherwise, they must discontinue HRT to allow confirmation of post-menopausal status prior to study enrolment
2
[ "Otherwise", ",", "they", "must", "discontinue", "HRT", "to", "allow", "confirmation", "of", "post-menopausal", "status", "prior", "to", "study", "enrolment" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02441101
1:28:chronic_disease,
Acute Myocardial infarction within 6 months of entry into the study
2
[ "Acute", "Myocardial", "infarction", "within", "6", "months", "of", "entry", "into", "the", "study" ]
[ 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02456857
13:31:cancer
Presence of metastatic disease
2
[ "Presence", "of", "metastatic", "disease" ]
[ 0, 0, 3, 3 ]
NCT02360579
1:17:treatment,19:27:treatment,37:51:treatment
Targeted therapy: MEK/BRAF or other targeted agent
2
[ "Targeted", "therapy", ":", "MEK/BRAF", "or", "other", "targeted", "agent" ]
[ 1, 1, 0, 1, 0, 0, 1, 1 ]
NCT02046395
12:28:cancer
History of multiple myeloma
2
[ "History", "of", "multiple", "myeloma" ]
[ 0, 0, 3, 3 ]
NCT02323880
21:51:cancer,122:134:treatment,195:216:treatment
Patients with known bone marrow metastatic disease will be eligible for study if they meet the blood counts (may receive transfusions provided they are not known to be refractory to red cell or platelet transfusions)
2
[ "Patients", "with", "known", "bone", "marrow", "metastatic", "disease", "will", "be", "eligible", "for", "study", "if", "they", "meet", "the", "blood", "counts", "(", "may", "receive", "transfusions", "provided", "they", "are", "not", "known", "to", "be", "r...
[ 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT02358187
,57:88:treatment,92:127:treatment,,170:207:treatment
Patients must be at least 3 weeks from the last dose of standard cytotoxic chemotherapy or myelosuppressive biological therapy and at least 1 week from the last dose of non-myelosuppressive biologic therapy
2
[ "Patients", "must", "be", "at", "least", "3", "weeks", "from", "the", "last", "dose", "of", "standard", "cytotoxic", "chemotherapy", "or", "myelosuppressive", "biological", "therapy", "and", "at", "least", "1", "week", "from", "the", "last", "dose", "of", "n...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT02064296
1:22:chronic_disease
Peripheral neuropathy of know cause that interferes with activities of daily living
2
[ "Peripheral", "neuropathy", "of", "know", "cause", "that", "interferes", "with", "activities", "of", "daily", "living" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02233868
48:68:chronic_disease,159:174:treatment,192:221:treatment,
Current or past DSM-IV or DSM-5 diagnosis of a psychiatric disorder (other than alcohol in AD participants and nicotine/caffeine use disorders) that required hospitalization (any length), or chronic medication management (more than 4 weeks) and that could impact brain function at the time of the study as determined by ...
2
[ "Current", "or", "past", "DSM-IV", "or", "DSM-5", "diagnosis", "of", "a", "psychiatric", "disorder", "(", "other", "than", "alcohol", "in", "AD", "participants", "and", "nicotine/caffeine", "use", "disorders", ")", "that", "required", "hospitalization", "(", "an...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02382549
1:17:treatment,25:32:treatment,34:42:treatment,44:53:treatment,74:97:treatment
Inhaled steroids (e.g.: Advair®, Flovent®, Azmacort®) are not permitted. Topical corticosteroids are acceptable
2
[ "Inhaled", "steroids", "(", "e.g", ".", ":", "Advair®", ",", "Flovent®", ",", "Azmacort®", ")", "are", "not", "permitted", ".", "Topical", "corticosteroids", "are", "acceptable" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT02473250
1:17:chronic_disease
blood dyscrasias
2
[ "blood", "dyscrasias" ]
[ 2, 2 ]
NCT02592707
65:89:treatment
Documentation of progressive disease based on RECIST v1.1 under prior anti-tumor therapy within 6 months of entry in the study (although the progression might have occurred more than 6 months before study entry)
2
[ "Documentation", "of", "progressive", "disease", "based", "on", "RECIST", "v1.1", "under", "prior", "anti-tumor", "therapy", "within", "6", "months", "of", "entry", "in", "the", "study", "(", "although", "the", "progression", "might", "have", "occurred", "more",...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01419561
1:17:chronic_disease,,
Thrombocytopenia (platelets<100,000 cells/microL)
2
[ "Thrombocytopenia", "(", "platelets", "<", "100,000", "cells/microL", ")" ]
[ 2, 0, 0, 0, 0, 0, 0 ]
NCT02584309
7:10:chronic_disease,37:59:treatment,89:134:treatment
Known HIV-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with dexrazoxane
2
[ "Known", "HIV-positivity", "on", "combination", "antiretroviral", "therapy", "because", "of", "the", "potential", "for", "pharmacokinetic", "interactions", "with", "dexrazoxane" ]
[ 0, 2, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1, 1, 1 ]
NCT02819440
8:19:treatment,
Use of medications that strongly alter CYP3A4 activity
2
[ "Use", "of", "medications", "that", "strongly", "alter", "CYP3A4", "activity" ]
[ 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02320292
4:18:cancer
No leukemic phase
2
[ "No", "leukemic", "phase" ]
[ 0, 3, 3 ]
NCT01639508
1:29:chronic_disease
gastrointestinal perforation
2
[ "gastrointestinal", "perforation" ]
[ 2, 2 ]
NCT02905188
1:14:chronic_disease,,
Heart failure of Class III-IV and / or C-D per NYHA Criteria
2
[ "Heart", "failure", "of", "Class", "III-IV", "and", "/", "or", "C-D", "per", "NYHA", "Criteria" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01993719
18:21:chronic_disease,50:59:treatment,146:162:chronic_disease
Seronegative for HIV antibody. (The experimental treatment being evaluated in this protocol depends on an intact immune system. Patients who are HIV seropositive can have decreased immune-competence and thus are less responsive to the experimental treatment and more susceptible to its toxicities.)
2
[ "Seronegative", "for", "HIV", "antibody", ".", "(", "The", "experimental", "treatment", "being", "evaluated", "in", "this", "protocol", "depends", "on", "an", "intact", "immune", "system", ".", "Patients", "who", "are", "HIV", "seropositive", "can", "have", "d...
[ 0, 0, 2, 2, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01130077
1:35:treatment
Allergy desensitization injections
2
[ "Allergy", "desensitization", "injections" ]
[ 1, 1, 1 ]
NCT01802346
19:31:treatment
Concurrent use of somatostatin
2
[ "Concurrent", "use", "of", "somatostatin" ]
[ 0, 0, 0, 1 ]
NCT03080142
22:45:treatment
Patients on systemic anticoagulation therapy
2
[ "Patients", "on", "systemic", "anticoagulation", "therapy" ]
[ 0, 0, 0, 1, 1 ]
NCT02583893
1:16:chronic_disease
unstable angina
2
[ "unstable", "angina" ]
[ 2, 2 ]
NCT02120222
1:29:chronic_disease,
gastrointestinal perforation within 28 days prior to beginning study treatment
2
[ "gastrointestinal", "perforation", "within", "28", "days", "prior", "to", "beginning", "study", "treatment" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02423863
1:21:cancer,36:41:cancer,143:148:chronic_disease,177:196:treatment
Head and neck cancer patients with tumor invading major blood vessels for whom there may be a risk of blockage or bleeding if inflammation or edema is transiently increased by Hiltonol injections
2
[ "Head", "and", "neck", "cancer", "patients", "with", "tumor", "invading", "major", "blood", "vessels", "for", "whom", "there", "may", "be", "a", "risk", "of", "blockage", "or", "bleeding", "if", "inflammation", "or", "edema", "is", "transiently", "increased", ...
[ 3, 3, 3, 3, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 1, 1 ]
NCT02719327
1:15:chronic_disease,
Claustrophobia requiring sedation for MRI
2
[ "Claustrophobia", "requiring", "sedation", "for", "MRI" ]
[ 2, 0, 0, 0, 0 ]
NCT01750567
,63:74:treatment,76:88:treatment,90:97:treatment,99:106:treatment,108:120:treatment,125:146:treatment
Patients who relapse after receiving a one or more courses of fludarabine, bendamustine, cytoxan, rituxan, chlorambucil, or campath based therapy
2
[ "Patients", "who", "relapse", "after", "receiving", "a", "one", "or", "more", "courses", "of", "fludarabine", ",", "bendamustine", ",", "cytoxan", ",", "rituxan", ",", "chlorambucil", ",", "or", "campath", "based", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 0, 1, 1, 1 ]
NCT01627301
13:29:chronic_disease
any serious systemic disease
2
[ "any", "serious", "systemic", "disease" ]
[ 0, 0, 2, 2 ]
NCT02811263
20:34:chronic_disease
Sentinel event and encephalopathy occurred only after birth
2
[ "Sentinel", "event", "and", "encephalopathy", "occurred", "only", "after", "birth" ]
[ 0, 0, 0, 2, 0, 0, 0, 0 ]
NCT02496585
22:43:chronic_disease
Diagnosis of diffuse radiation pneumonitis
2
[ "Diagnosis", "of", "diffuse", "radiation", "pneumonitis" ]
[ 0, 0, 0, 2, 2 ]
NCT02562716
20:38:chronic_disease
Patients must have measurable disease in the pancreas
2
[ "Patients", "must", "have", "measurable", "disease", "in", "the", "pancreas" ]
[ 0, 0, 0, 2, 2, 0, 0, 0 ]
NCT02441140
4:22:chronic_disease,36:64:cancer
No measurable disease or suspected Stage I or II ovarian cancer on preoperative imaging
2
[ "No", "measurable", "disease", "or", "suspected", "Stage", "I", "or", "II", "ovarian", "cancer", "on", "preoperative", "imaging" ]
[ 0, 2, 2, 0, 0, 3, 3, 3, 3, 3, 3, 0, 0, 0 ]
NCT00085982
56:71:treatment
The inclusion criteria should include any patient with extreme insulin resistance who has appropriately low leptin levels
2
[ "The", "inclusion", "criteria", "should", "include", "any", "patient", "with", "extreme", "insulin", "resistance", "who", "has", "appropriately", "low", "leptin", "levels" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01696734
1:9:chronic_disease,11:19:chronic_disease,24:47:chronic_disease
valvular, ischemic, or pulmonary heart disease
2
[ "valvular", ",", "ischemic", ",", "or", "pulmonary", "heart", "disease" ]
[ 2, 0, 2, 0, 0, 2, 2, 2 ]
NCT00720785
,34:50:treatment,62:84:treatment,110:120:cancer
At least 4 weeks since any prior systemic therapy (excluding corticosteroid therapy) to treat the underlying malignancy (standard or investigational)
2
[ "At", "least", "4", "weeks", "since", "any", "prior", "systemic", "therapy", "(", "excluding", "corticosteroid", "therapy", ")", "to", "treat", "the", "underlying", "malignancy", "(", "standard", "or", "investigational", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0 ]
NCT02446210
81:88:chronic_disease,128:142:treatment,144:153:treatment,158:183:treatment
Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic antidepressants
2
[ "Receiving", "drugs", "acting", "primarily", "on", "the", "central", "nervous", "system", ",", "which", "lower", "the", "seizure", "threshold", "such", "as", "antipsychotic", "drugs", "(", "chlorpromazine", ",", "clozapine", ")", "or", "tricyclic", "antidepressant...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 1, 1 ]
NCT02769000
12:19:chronic_disease
History of seizure activity
2
[ "History", "of", "seizure", "activity" ]
[ 0, 0, 2, 0 ]
NCT00720785
19:28:chronic_disease
Ongoing or active infection
2
[ "Ongoing", "or", "active", "infection" ]
[ 0, 0, 0, 2 ]
NCT02162420
1:56:chronic_disease
Dyskeratosis Congenita (DC) with evidence of BM failure
2
[ "Dyskeratosis", "Congenita", "(", "DC", ")", "with", "evidence", "of", "BM", "failure" ]
[ 2, 2, 2, 2, 2, 2, 2, 2, 0, 0 ]
NCT02695433
12:25:chronic_disease,27:38:chronic_disease,40:45:chronic_disease,47:63:chronic_disease,68:83:chronic_disease
history of heart disease, respiratory, renal, gastrointestinal, or hepatic disease
2
[ "history", "of", "heart", "disease", ",", "respiratory", ",", "renal", ",", "gastrointestinal", ",", "or", "hepatic", "disease" ]
[ 0, 0, 2, 2, 0, 2, 0, 2, 0, 2, 0, 0, 2, 2 ]
NCT02911467
13:29:chronic_disease,63:72:treatment,89:101:treatment
Patients on anti-coagulation they must be able to safely stop treatment for purposes of tumor biopsy
2
[ "Patients", "on", "anti-coagulation", "they", "must", "be", "able", "to", "safely", "stop", "treatment", "for", "purposes", "of", "tumor", "biopsy" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 1, 1 ]
NCT02203513
,133:160:treatment
Patients should have recurrent platinum-resistant - defined as disease recurrence by imaging within 6 months of the last receipt of platinum-based chemotherapy
2
[ "Patients", "should", "have", "recurrent", "platinum-resistant", "-", "defined", "as", "disease", "recurrence", "by", "imaging", "within", "6", "months", "of", "the", "last", "receipt", "of", "platinum-based", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02900794
1:23:chronic_disease
Chronic rhinosinusitis as described by the guidelines published in the 2015 Clinical practice guideline (update)
2
[ "Chronic", "rhinosinusitis", "as", "described", "by", "the", "guidelines", "published", "in", "the", "2015", "Clinical", "practice", "guideline", "(", "update", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03112174
26:29:cancer,230:270:treatment,275:306:treatment
Pathologically confirmed MCL (in tumor tissue), with documentation of either overexpression of cyclin D1 in association with other relevant markers (eg, CD19, CD20, PAX5, CD5) or evidence of t(11;14) as assessed by cytogenetics, fluorescent in situ hybridization (FISH), or polymerase chain reaction (PCR)
2
[ "Pathologically", "confirmed", "MCL", "(", "in", "tumor", "tissue", ")", ",", "with", "documentation", "of", "either", "overexpression", "of", "cyclin", "D1", "in", "association", "with", "other", "relevant", "markers", "(", "eg", ",", "CD19", ",", "CD20", "...
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0 ]
NCT03038269
1:16:chronic_disease
Visual problems (uncorrected by glasses/contact lenses)
2
[ "Visual", "problems", "(", "uncorrected", "by", "glasses/contact", "lenses", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02339376
21:34:cancer
Rapidly progressive brain lesions
2
[ "Rapidly", "progressive", "brain", "lesions" ]
[ 0, 0, 3, 3 ]
NCT02947945
1:17:chronic_disease
Palpable purpura
2
[ "Palpable", "purpura" ]
[ 2, 2 ]
NCT02488967
8:23:chronic_disease
Active cardiac disease
2
[ "Active", "cardiac", "disease" ]
[ 0, 2, 2 ]
NCT01445821
4:15:treatment,87:128:treatment,141:152:chronic_disease,161:199:treatment
On cardiac MRI, a diastolic septal bounce or diastolic septal flattering (D-sign), or diffuse myocardial gadolinium enhancement, or diffuse hypokinesis (patchy late gadolinium myocardial enhancement are not exclusion criteria)
2
[ "On", "cardiac", "MRI", ",", "a", "diastolic", "septal", "bounce", "or", "diastolic", "septal", "flattering", "(", "D-sign", ")", ",", "or", "diffuse", "myocardial", "gadolinium", "enhancement", ",", "or", "diffuse", "hypokinesis", "(", "patchy", "late", "gado...
[ 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 2, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0 ]
NCT02819141
,,104:112:treatment,114:127:treatment,129:137:treatment,139:147:treatment,149:158:treatment,160:168:treatment,170:179:treatment,181:189:treatment,191:202:treatment,204:219:treatment
received at least one intravenous bolus dose of a sedative/opioid medication in the previous 24 hours (fentanyl, hydromorphone, ketamine, morphine, midazolam, diazepam, lorazepam, propofol, haloperidol, dexmedetomidine)
2
[ "received", "at", "least", "one", "intravenous", "bolus", "dose", "of", "a", "sedative/opioid", "medication", "in", "the", "previous", "24", "hours", "(", "fentanyl", ",", "hydromorphone", ",", "ketamine", ",", "morphine", ",", "midazolam", ",", "diazepam", ",...
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0, 1, 0 ]
NCT02013492
52:61:treatment
Patients may have had any number of prior systemic therapies
2
[ "Patients", "may", "have", "had", "any", "number", "of", "prior", "systemic", "therapies" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01842399
1:13:treatment
Amphetamines
2
[ "Amphetamines" ]
[ 1 ]
NCT01918683
8:16:chronic_disease,
Active GI bleed within 2 weeks of study enrollment
2
[ "Active", "GI", "bleed", "within", "2", "weeks", "of", "study", "enrollment" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02370095
1:29:chronic_disease,,,
Severe chronic liver disease (Child-Pugh Score 11-15)
2
[ "Severe", "chronic", "liver", "disease", "(", "Child-Pugh", "Score", "11-15", ")" ]
[ 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT01572480
1:14:treatment,
Immunoparesis with reduction of 2 uninvolved immunoglobulin isotypes
2
[ "Immunoparesis", "with", "reduction", "of", "2", "uninvolved", "immunoglobulin", "isotypes" ]
[ 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02632721
1:34:cancer
Acute promyelocytic leukemia (APL, French-American-British (FAB) subtype M3), according to WHO classification
2
[ "Acute", "promyelocytic", "leukemia", "(", "APL", ",", "French-American-British", "(", "FAB", ")", "subtype", "M3", ")", ",", "according", "to", "WHO", "classification" ]
[ 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02516670
6:29:chronic_disease
Have end stage renal disease
2
[ "Have", "end", "stage", "renal", "disease" ]
[ 0, 2, 2, 2, 2 ]
NCT02516670
122:134:treatment
Patients who require frequent (several times a day) monitoring of their blood glucose or patients who have recently been hospitalized for glucose control
2
[ "Patients", "who", "require", "frequent", "(", "several", "times", "a", "day", ")", "monitoring", "of", "their", "blood", "glucose", "or", "patients", "who", "have", "recently", "been", "hospitalized", "for", "glucose", "control" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT00338377
57:66:treatment,
Patients who have been previously treated with other IT therapies are eligible, as long as there is at least a 2 week wash out period
2
[ "Patients", "who", "have", "been", "previously", "treated", "with", "other", "IT", "therapies", "are", "eligible", ",", "as", "long", "as", "there", "is", "at", "least", "a", "2", "week", "wash", "out", "period" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]